3584 results for «2015»
3584 results
Double jeopardy: coronary disease in patients undergoing TAVI
17 May 2022 – From EuroPCR 2022
Through the presentation of real-life clinical cases, this session will allow you to discover the use of ALLEGRA for valve-in-valve TAVI, understand the management of coronary artery disease in TAVI patients, better detect when and how to protect coronary arteries during TAVI, or even learn how...
How to deal with calcified CTO
17 May 2022 – From EuroPCR 2022
In this dedicated session from EuroPCR 2022, listen to Gabriele Luigi Gasparini talk about procedural challenges and device selection for calcified CTO, while James Spratt looks at how to deal with long, calcified CTO, and Kambis Mashayekhi discusses problems and solutions in calcified CTO.
EuroPCR 2022 Hotlines / Late-Breaking Trials in mitral and tricuspid: MITRA-TUNE, MitraBridge, TriCLASP, CLASP TR, and more!
19 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in mitral and tricuspid! MitraClip in atrial functional mitral regurgitation, two-year outcomes of MitraClip as a bridge to heart transplantation, TriCLASP post-market study, CLASP TR study one-year results, Cardioband TR early feasibility study, and initial 30-day results from...
Leading clinical evidence while disrupting the mitral paradigm with clip therapy
17 May 2022 – From EuroPCR 2022
Watch this EuroPCR 2022 session with Nicole Karam, Stephan Baldus, Fabien Praz, Wolfgang Rottbauer, and Martin Swaans, and learn how the recent guidelines change the game in mitral disease management, how they can be implemented in practice, and what are the latest real-life clip data and...
Advances in renal denervation: from patient selection to procedure
17 May 2022 – From EuroPCR 2022
For this EuroPCR 2022 session, Felix Mahfoud is joined by David Kandzari, Rasha Al-Lamee, Flavio Ribichini, and Andrew Sharp to talk about renal denervation: hear real-life experiences and get the latest preclinical and clinical data on the long-term safety and efficacy of the radiofrequency renal denervation...
Valve-in-valve: the journey starts with the first prosthesis
17 May 2022 – From EuroPCR 2022
In this EuroPCR 2022 session featuring Philip Maccarthy, Julia Mascherbauer, Hendrik Treede, Christian Hengstenberg, Radoslaw Parma, and Giuseppe Tarantini, analyze the impact of valve-in-valve interventions on lifetime management, learn about particular clinical considerations and the procedural technique of TAVI-in-TAVI procedures, and appreciate the potential pitfalls of...
Advancing the treatment of uncontrolled hypertension with ultrasound renal denervation
17 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session, which covers the latest clinical evidence around catheter-based ultrasound renal denervation, will also enable you to appreciate the distinct features of this approach, to understand perspectives on patient selection and patient preference, and to learn how to introduce and establish interventional hypertension therapy.
Transradial approach, from complex PCI to peripheral intervention
19 May 2022 – From EUROPCR 2022
Watch this session if you want to demonstrate how to optimise challenging coronary and peripheral cases using dedicated devices in transradial approach, to appreciate the value of transradial approach for complex PCI and carotid artery stenting and to acknowledge Ultimaster DES results in high bleeding risk patient...
Start treating refractory angina patients with Reducer therapy - Practical aspects
17 May 2022 – From EuroPCR 2022
Looking at a 75-year-old male patient with HTA, diabetes, and hypothyroidism, a history of coronary artery disease treated with PCI of the RCA, and a previous coronary angiography showing preserved LVEF and in-stent restenosis of the RCA, you will learn in this EuroPCR 2022 session how...
DCB and the possibility of a clean vessel
17 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session aims to show, based on real-life cases, that even complex coronary disease can be treated without the need for permanent coronary stents. Learn how to prepare the vessel, deliver the therapy, and assess immediate outcomes after "DCB-alone" PCI, discuss de novo, small vessels, and...
2022: a tipping point in the treatment of mitral regurgitation patients
17 May 2022 – From EuroPCR 2022
With study outcomes and clinical cases, this EuroPCR 2022 session will enable you to discuss the anatomical considerations that define suitable candidates for treatment of mitral regurgitation with the PASCAL platform and highlight key differentiators and tips and tricks for its use.
How to decrease operator dependence on vessel opacification during PCI? A crash course on ultra-low contrast coronary interventions
17 May 2022 – From EuroPCR 2022
Watch this EuroPCR 2022 session to become aware of the importance of relying on less contrast injections to guide PCI in complex patients, to learn what skills are required and tools available to perform ultra-low contrast coronary interventions, and to share and discuss such a recorded intervention from...
Sirolimus coated balloon and coronary artery disease: expanding the treatment indications
17 May 2022 – From EuroPCR 2022
Through a case presentation, as well as upcoming studies and rationale for the Food and Drug Administration, the aim of this EuroPCR 2022 session is to help you answer the following questions: how can the use of a sirolimus-coated DCB be expanded in new and challenging treatment indications? Why is...
Lifetime management of patients with severe aortic stenosis - Securing long-term benefits
17 May 2022 – From EuroPCR 2022
Watching this EuroPCR 2022 session on lifetime management of patients with aortic stenosis will help you understand the importance of the heart team in patient specific treatment and how procedural refinement may optimise long-term outcomes.
Stent failure: how to treat, how to prevent
18 May 2022 – From EuroPCR 2022
With 2 expert interviews, a stent failure case example, and a recorded best practice case to prevent stent failure in this EuroPCR 2022 session, understand why unraveling the mechanism of stent failure is essential for optimal treatment, receive tips and tricks to effectively treat stent failure,...
Robotic-assisted intervention: latest clinical insights and applications for complex PCI
18 May 2022 – From EuroPCR 2022
How does robotic assistance work in practice in the cathlab? This is the main question this EuroPCR 2022 session aims to answer. Watch it if you wish to understand the functions and capabilities of the Corpath GRX system, learn from a recorded case about best procedural practices and workflow...
Redefining indications for drug-eluting balloons in complex PCI - The role of sustained limus release
18 May 2022 – From EuroPCR 2022
Thanks to this EuroPCR 2022 session, discuss how sustained limus release technology can broaden DEB indications, learn about the decision-making process on the use of DEB adjacent to DES in complex PCI, and review DEB specific implantation techniques to achieve optimal outcomes for the patient.
The right valve choice for TAVI patient longevity and durability
18 May 2022 – From EuroPCR 2022
Watch this session to learn about the impact of age and life expectancy on decision-making for TAVI, to become aware of the durability data of the current TAVI platform, and to revise contemporary implantation techniques and procedural goals for future TAVI-in-TAVI.
The ability to transform coronary artery disease treatment: innovative nanotechnology-based sirolimus DES and DCB platforms
18 May 2022 – From EuroPCR 2022
Alexandre Abizaid, Marco Valgimigli, Fazila Malik, Luca Testa, Patrick W. Serruys, Damiano Regazzoli, Kumar Prathap, and Sandeep Basavarajaiah take turns in this session to discuss two innovative technologies: a stent platform with nanotechnology and a novel drug-coated balloon (DCB). These novel technologies both have unique features...
Mitral replacement: expanding patient options, even mitral annular calcification!
18 May 2022 – From EUROPCR 2022
The objectives of this session from EuroPCR 2022 are to provide the best pathway for mitral regurgitation management, to learn about early commercial TMVR experience and to discover treatment options for mitral annular calcification patients.
